Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongguan HEC TaiGen Biopharmaceuticals
Dongguan, Guangdong Sheng, Chinataigenbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dongguan HEC TaiGen Biopharmaceuticals is a joint venture focused on developing small molecule antivirals for hepatitis C. Its lead asset, furaprevir (TG‑2349), an oral NS3/4A protease inhibitor, has completed Phase III trials in China for chronic hepatitis C and remains in late-stage development elsewhere. The company also develops other small molecules such as DAG181 for similar indications. Clinical results show completion of pivotal studies with ongoing regulatory and commercial activities.
- Therapeutic areas
- NephrologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Major partnership is the joint venture itself between YiChang HEC and TaiGen Biotechnology. No additional major pharma partnerships disclosed publicly.
Beyond the preview
Go deeper on Dongguan HEC TaiGen Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dongguan HEC TaiGen Biopharmaceuticals.